SCI Pharmtech, Inc. (TPE:4119)

SCI Pharmtech Revenue

SCI Pharmtech had revenue of 375.80M TWD in the quarter ending March 31, 2026, with 4.30% growth. This brings the company's revenue in the last twelve months to 1.36B, down -13.65% year-over-year. In the year 2025, SCI Pharmtech had annual revenue of 1.34B, down -11.81%.

• Revenue (ttm): 1.36B
• Revenue Growth: -13.65%
• P/S Ratio: 4.10
• Revenue / Employee: 5.69M
• Employees: 245
• Market Cap: 5.58B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.34B	-180.02M	-11.81%
Dec 31, 2024	1.52B	319.58M	26.54%
Dec 31, 2023	1.20B	304.42M	33.83%
Dec 31, 2022	899.74M	35.52M	4.11%
Dec 31, 2021	864.22M	-1.83B	-67.86%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 8, 2026

Data Sources Report a data error